>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Global Standardized Financials

5.34 -0.28 (-4.90%) 04/17/2026
Aptevo Therapeutics Inc. (APVO)
Income Statement
(Values in Thousands)
 Q4 2025 (Dec 31, 2025)Q3 2025 (Sep 30, 2025)Q2 2025 (Jun 30, 2025)Q1 2025 (Mar 31, 2025)Q4 2024 (Dec 31, 2024)Q3 2024 (Sep 30, 2024)Q2 2024 (Jun 30, 2024)Q1 2024 (Mar 31, 2024)Q4 2023 (Dec 31, 2023)Q3 2023 (Sep 30, 2023)Q2 2023 (Jun 30, 2023)Q1 2023 (Mar 31, 2023)Q4 2022 (Dec 31, 2022)Q3 2022 (Sep 30, 2022)Q2 2022 (Jun 30, 2022)Q1 2022 (Mar 31, 2022)Q4 2021 (Dec 31, 2021)Q3 2021 (Sep 30, 2021)Q2 2021 (Jun 30, 2021)Q1 2021 (Mar 31, 2021)Q4 2020 (Dec 31, 2020)Q3 2020 (Sep 30, 2020)Q2 2020 (Jun 30, 2020)Q1 2020 (Mar 31, 2020)Q4 2019 (Dec 31, 2019)Q3 2019 (Sep 30, 2019)Q2 2019 (Jun 30, 2019)Q1 2019 (Mar 31, 2019)Q4 2018 (Dec 31, 2018)Q3 2018 (Sep 30, 2018)Q2 2018 (Jun 30, 2018)Q1 2018 (Mar 31, 2018)Q4 2017 (Dec 31, 2017)Q3 2017 (Sep 30, 2017)Q2 2017 (Jun 30, 2017)Q1 2017 (Mar 31, 2017)Q4 2016 (Dec 31, 2016)Q3 2016 (Sep 30, 2016)Q2 2016 (Jun 30, 2016)Q1 2016 (Mar 31, 2016)
Net Income-5,806-7,549-6,204-6,408-6,312-5,101-5,883-6,834
Revenue
Cost Of Revenue8171106
Gross Profit-81-71-106
Operating Expenses5,9157,6106,2266,4806,3115,2136,0246,877
Selling General and Administrative Expenses2,4613,5662,8982,8472,5022,1102,3813,231
Research and Development Expenses3,5354,0443,3283,6333,8803,1033,6433,646
Other Expenses-81-71
Cost And Expenses5,9967,6106,2266,4806,3825,2136,0246,983
Operating Income-5,996-7,610-6,226-6,480-6,382-5,213-6,024-6,983
Interest Income
Income Tax Expense
Income Before Tax-5,806-7,549-6,204-6,408-6,312-5,101-5,883-6,834
Earning Per Share Basic-159.33-40.13-151.29-1,581.72-86.56-357.85-1,236.81-7,364.07
Earning Per Share Diluted-159.33-40.13-151.29-1,581.72-86.56-357.85-1,236.81-7,364.07
weighted Average Shares Outstanding3225414731451
weighted Average Shares Outstanding (Diluted)3225414731451
Gross Margin
EBIT Margin
Profit Margin
EBITDA-5,886-7,500-6,177-6,419-6,311-5,129-5,933-6,877
Earning Before Tax Margin

Market News ×
Loading news…